This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options. © 2018 The Author(s).
Nobel committee honors tumor immunologists
D'Orazi, Gabriella;
2018-01-01
Abstract
This commentary wishes to highlight the 2018 Nobel Prize in Medicine awarded to two cancer immunotherapy scientists, Prof James Allison and Prof Tasuku Honjo, for their discovery on unleashing the body's immune system to attack cancer. Their studies have led to the development of an entire class of drugs that hopefully will bring lasting remissions to many patients who had run out of options. © 2018 The Author(s).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
JECCR Commentary 2018.pdf
non disponibili
Licenza:
Dominio pubblico
Dimensione
830.44 kB
Formato
Adobe PDF
|
830.44 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
